|
|
281 Magnolia Avenue, Suite 300
Goleta, CA 93117 USA
phone:805-681-7000
fax:805-681-7252
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.baronova.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Developing novel obesity device for nonsurgical treatment |
|
| Management |
| HUGH NARCISO, M.S., Founder/President and CEO; ANDREA KELLY, Director, Quality Assurance; CLIFF KLINE, Director, Clinical Operations and Regulatory Affairs |
| |
|
|
| |
|
| Keywords |
| obesity, nonsurgical |
|
|
|
| Description |
|
BaroNova is an early-stage company focused on developing innovative nonsurgical, nonpharmacologic therapies for the treatment of obesity. |
|
|
| Status |
| BaroNova expects to rapidly enter into chronic animal studies followed by OUS human studies. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members